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Abstract: Telomerase negative cancer cell types use the Alternative Lengthening of Telomeres 
(ALT) pathway to elongate telomeres ends. Here, we show that silencing human DNA polymerase 
(Pol λ) in ALT cells represses ALT activity and induces telomeric stress. In addition, replication 
stress in the absence of Pol λ, strongly affects the survival of ALT cells. In vitro, Pol λ can promote 
annealing of even a single G-rich telomeric repeat to its complementary strand and use it to prime 
DNA synthesis. The noncoding telomeric repeat containing RNA TERRA and replication protein A 
negatively regulate this activity, while the Protection of Telomeres protein 1 (POT1)/TPP1 heterodi-
mer stimulates Pol λ. Pol λ associates with telomeres and colocalizes with TPP1 in cells. In sum-
mary, our data suggest a role of Pol λ in the maintenance of telomeres by the ALT mechanism. 
Keywords: alternative lengthening of telomeres (ALT), DNA polymerase λ; DNA double-strand 
breaks (DSBs), extra-chromosomal telomeric repeats (ECTRs), promyelocytic leukemia (PML) bod-
ies; telomere dysfunction-induced foci (TIFs), telomere stress; microhomology-mediated strand 
transfer (MMST) activity 
 
1. Introduction 
The Alternative Lengthening of Telomeres (ALT) is used by telomerase negative can-
cer cells to avoid shortening of telomeric DNA. The G-rich single strand (ss) 3′-end of 
telomeric DNA invades the double strand (ds) of another telomeric DNA tract, forming a 
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D-loop structure. DNA synthesis is then initiated at the 3′-end of the annealed G-strand, 
using the complementary C-rich strand as a template [1]. 
The ALT process can be initiated by a homologous recombination (HR) mechanism 
or by an HR-independent pathway [2]. In the HR-dependent mechanism, the ss G-rich 
overhang binding protein Protection of Telomeres protein 1 POT1, which represses HR, 
is replaced by replication protein A (RP-A) [3], allowing binding of RAD51, which pro-
motes D-loop formation followed by elongation of the ss G-rich strand using the comple-
mentary strand as a template. In the HR-independent mechanism, instead, circular telo-
meric DNA molecules called extra-chromosomal telomeric repeats (ECTRs) are generated 
[4–6]. In particular, ECTRs constituted by a continuous C-rich telomeric strand paired to 
a discontinuous (containing nicks or gaps) complementary strand, called c-circles, are spe-
cifically generated during ALT [7]. It has been proposed that the G-rich ss 3′-end of a te-
lomere may pair to the complementary strand on the c-circle, providing a template for 
rolling circle-type DNA synthesis [8,9]. 
ALT can also result from repair of DNA double-strand breaks (DSBs) at internal te-
lomeric sequences. Telomeres are genomic regions difficult to replicate [10–12] and spon-
taneous DSBs occur frequently at telomeric regions, causing a persistent DNA damage 
response [11]. In addition, ALT cells are particularly prone to DSBs at telomeres, as a con-
sequence of replication fork stalling and mutations in the ATRX/DAXX chromatin remod-
eling complex, often present in ALT cells [13,14]. Telomeric DSBs were indeed shown to 
promote ALT-dependent telomere recombination [15]. Internal DSBs at telomeres can be 
repaired also by an alternative microhomology-mediated non-homologous end joining 
pathway (a-NHEJ) [2]. The a-NHEJ dependent on PARP-1 and DNA ligase 3 has been 
suggested to play a role in the repair of internal telomeric DSBs [16,17]. Moreover, in ALT 
cells, DSBs can trigger unidirectional break-induced replication (BIR), resulting in telo-
mere elongation [18,19]. Two BIR-dependent pathways have been identified: one RAD52-
depedent, which does not lead to c-circle formation, and one RAD52-independent, which 
relies on Bloom helicase and DNA polymerase (Pol) δ, which is essential for c-circle gen-
eration [20] and may be linked to the processing of collapsed replication forks [21]. 
So far, the identity of the Pols involved in the elongation step of ALT has remained 
elusive. An alternative replisome complex formed by proliferating cell nuclear antigen, 
replication factor C and Pol δ, has been shown to operate in the context of BIR-dependent 
telomere synthesis in ALT cells [19]. Experimental evidence also supports a role of the 
repair enzyme Pol θ in the a-NHEJ pathway responsible for telomere fusions in the pres-
ence of non-functional shelterin complexes, but it is not known whether Pol θ also con-
tributes to repair of internal telomere DSBs in ALT cells [22,23]. Finally, a study suggested 
a role for the specialized translesion synthesis (TLS) Pol η in promoting replication stress 
tolerance at ALT telomeres, possibly during HR-dependent replication fork restart or by 
allowing bypass of replication blocks such as G-quadruplex and oxidative lesions [24]. 
Whether additional Pols operate in the context of the various ALT pathways is currently 
not known. 
All the pathways proposed to initiate ALT and described above require enzymes able 
to catalyze DNA strand transfer and annealing reactions followed by DNA synthesis. Hu-
man Pol λ is involved in the tolerance of oxidative DNA damage and in the NHEJ repair 
of DSBs [25] and possesses microhomology-mediated strand annealing and elongation 
activities on normal or repetitive DNA sequences [26,27]. This microhomology mediated 
strand transfer (MMST) activity is not sequence-specific, requiring only a minimal homol-
ogy between the two strands to be joined. Pol λ is also important to overcome DNA rep-
lication stress in the U2OS osteosarcoma ALT human cell line. In fact, disabling the S-
phase checkpoint together with a silencing of Pol λ results in synthetic lethality in the 
presence of hydroxyurea (HU) -induced replication fork stalling [28]. 
Here, we show that silencing human Pol λ in two ALT cell lines strongly reduces 
ALT-dependent c-circle accumulation and ALT-associated promyelocytic leukemia 
(PML) bodies formation. Moreover, in the absence of Pol λ, ALT cells, but not telomerase-
Int. J. Mol. Sci. 2021, 22, 2365 3 of 28 
 
 
positive cells, show increased sensitivity to HU-induced replication stress and accumulate 
DNA damage at telomeres. In vitro, Pol λ promoted annealing of even a single G-rich 
telomeric repeat to its complementary strand, both on linear and D-loop substrates, and 
used it to prime DNA synthesis. Telomeric repeats containing RNA (TERRA) and RP-A 
negatively regulated this activity, while the POT1/TPP1 complex stimulated Pol λ. Pol λ 
associated with telomeres and colocalized with TPP1 in cells. Our data suggest a previ-
ously undetected role of Pol λ in the ALT process. 
2. Results 
2.1. Silencing of Human DNA Polymerase λ Specifically Affects the Viability of ALT Cell Lines 
in the Presence of Replication Stress 
Pol λ was silenced in the telomerase-negative cell line Saos-2 (Figure 1A, lanes 3, 4; 
Figure S3), which uses the ALT mechanism to elongate its telomeric DNA ends. As shown 
in Figure 1B, silencing of Pol λ alone already significantly reduced cell viability, compared 
to controls. A similar reduction in viability was observed in control cells after stalling rep-
lication forks with HU treatment for 24 h, followed by 24 h of recovery, to allow for repli-
cation fork restart, in order to highlight failure in overcoming replication stress (Figure 
1B). Combination of HU treatment with Pol λ silencing resulted in an additional loss of 
viability, suggesting that the effects of HU-induced replication stress were worsened by 
the absence of Pol λ. In a similar experiment, silencing of Pol λ in U2OS ALT cells (Figure 
1A, lanes 5, 6; Figure S4) reduced cell viability similarly to HU treatment. However, com-
bination of Pol λ silencing and HU treatment caused a further reduction in viability (Fig-
ure 1C), as observed with Saos-2 cells and according to previous observations [28]. In BJ-
hTERT cells, which use telomerase-dependent elongation of the telomeric DNA ends, si-
lencing of Pol λ was effective (Figure 1A, lanes 1, 2) and reduced cell viability (Figure 1D), 
to a similar extent as HU treatment alone. However, contrary to what has been observed 
on ALT cell lines, a combination of Pol λ silencing with HU treatment did not result sig-
nificantly in further loss of viability (Figure 1D). 
  




Figure 1. Silencing of human DNA polymerase λ specifically affects viability of ALT cell lines. (A) Western Blot analysis of Pol 
λ expression in BJ-hTERT, Saos-2 and U2OS cell lines either treated with scrambled siRNA control (lanes 1, 3, 5, respectively), 
or transfected with the anti-Pol λ siRNA si98 (lanes 2, 4) or the anti-Pol λ SMARTpool siRNAs cocktail (lane 6). (B) Viability of 
Saos-2 cells either treated with scrambled siRNA control (black bars) or silenced for Pol λ (grey bars) was measured by MTS 
assays. Cells were either untreated or treated with HU for 24 h and then viability was measured after an additional 24 h recovery 
in the absence of treatments. (C) As in panel B, but with the U2OS cell line. (D) As in panel B, but with the BJ-hTERT cell line. 
In all panels error bars represent ± SD of four independent experiments. χ2 p values are shown on top of the bars. n.s., not 
statistically significant (χ2 p value > 0.02). *, χ2 p value <0.05. **, χ2 p value <0.01. 
These results suggested that Pol λ may play a specific role in overcoming DNA rep-
lication stress in ALT cells, but not in telomerase-expressing cells. 
2.2. The Levels of DNA Polymerase λ Correlate with the Cellular ALT Activity 
In order to verify whether the ALT process was directly affected by the absence of 
Pol λ, we monitored the levels of c-circles, a validated marker for ALT activity, in both 
Saos-2 and U2OS cells. Different amounts of amplified c-circles DNA from Saos-2 (Figure 
2A) or U2OS cells (Figure 2C), either wild type or silenced for Pol λ, were spotted on a 
membrane and hybridized with a 32P-labelled telomeric probe. Amplified DNA from te-
lomerase-positive HeLa cells was used as a negative control. Both Pol λ-silenced ALT cell 
lines (Figure 2A, mid lane, Figure 2C, bottom lane) showed a reduction in c-circle DNA, 
with respect to the scrambled siRNA-treated cells (Figure 2A, bottom line; Figure 2C, mid 
lane). Quantification of three independent experiments indicated that Pol λ silencing re-
duced c-circle formation in Saos-2 cells by 50% (Figure 2B). 




Figure 2. The levels of DNA polymerase λ correlate with the cellular ALT activity. (A) Dot blot assay for c-circle formation. 
Different amounts of amplified c-circle DNA from HeLa (top lane) or Saos-2 cells, either silenced for Pol λ (mid lane) or treated 
with scrambled control (bottom lane), were spotted on a membrane and hybridized with a radioactive telomeric probe. (B) 
Quantification of c-circles in SI control vs. Pol λ KD Saos-2 cells. Values are the mean of three independent experiments, each 
comprising three different amounts of DNA as in panel A. Error bars are ± S.D. The χ2 p value is shown on top. **, χ2 p value 
<0.01. (C) As in panel A, but with c-circle DNA amplified from HeLa cells (top lane) or U2OS cells, either silenced for Pol λ 
(bottom lane) or treated with scrambled control (mid lane). (D) Dot blot assay for c-circle formation. Different amounts of am-
plified c-circle DNA from U2OS cells transfected with the empty vector (EV, lane 1), U2OS cells overexpressing Pol λ (OE, lane 
2), U2OS cells silenced for Pol λ (KD, lane 3) or untreated U2OS cells (Control, lane 4), were spotted on a membrane and hy-
bridized with a radioactive telomeric probe. (E) Western Blot analysis showing the levels of Pol λ in U2OS cells transfected with 
the Pol λ expression vector (corresponding to Pol λ OE of panel C). EV, U2OS cells transfected with the empty vector as negative 
control. (F) Confocal microscopy imaging of colocalization of PML protein (green) and telomeres (red) in U2OS cells either 
silenced for Pol λ (right panels) or control (left panels). Nuclei were stained with DAPI (blue). Representative colocalization 
events are indicated by white arrows. (G) Statistical analysis of three independent experiments comparing the number of colo-
calization events in control and silenced cells (n. of cells = 100 for each condition). The number of colocalization events observed 
within a single cell is shown for control (circles) and silenced (triangles) cells. χ2 p value is shown on top (***, χ2 p value < 0.0001). 
(H) Western Blot analysis showing the levels of Pol λ in U2OS cells either transfected with scramble control siRNA (lane 1) or 
anti-Pol λ siRNA (lane 2). 
In order to investigate whether the ALT activity was directly dependent on Pol λ 
levels, the amount of c-circles was next compared between U2OS cells wild type and either 
silenced for Pol λ or overexpressing ectopic c-Myc Pol λ. As expected, silencing of Pol λ 
reduced c-circles formation with respect to wild type cells (Figure 2D, compare lane 3 with 
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lanes 1, 4), while high levels of Pol λ (assessed by Western Blot in Figure 2E) translated 
into increased amount of c-circles with respect to wild type cells (Figure 2D, compare lane 
2 with lanes 1, 4) thus suggesting that the higher level of Pol λ leads to enhanced ALT 
activity. 
The effect of Pol λ silencing on the formation of ALT-associated PML nuclear bodies 
(APBs) was tested by fluorescence microscopy analysis of the colocalization of the PML 
protein with telomeres. APBs are specific markers for ALT activity and are considered 
sites of telomere DNA synthesis [29]. Cells were sliced into 1µm z-stacks to quantify the 
co localization in nuclei. Silencing of Pol λ in U2OS cells (Figure 2H; Figure S5) resulted 
in a highly significant reduction of APBs with respect to control U2OS cells (Figure 2F,G). 
Finally, the effects of Pol λ silencing on the cell cycle in ALT cells. As shown in Figure 
3A,B, silencing of Pol λ in U2OS cells resulted in an accumulation of cells in late S-G2 
phases compared to the scrambled control at the 9 h time point (28.59% vs. 17.67% respec-
tively), with a concomitant reduced number of cells progressing to the G1 phase of the 
next cycle (36.41% vs. 44.55%, respectively). On the other hand, silencing of Pol λ in BJ-
hTERT immortalized fibroblasts, which are telomerase proficient, did not result in a sig-
nificant delay in the cell cycle (Figure 3C–E). This suggested that silencing of Pol λ resulted 
in a slower progression through late S-G2 phases, specifically in ALT cells. 
  




Figure 3. Pol λ silencing causes a slower progression through late S-G2 phases in ALT cells. The cell cycle progression was 
monitored by FACS. The orange gate indicates the percentage of cells in the G1-phase. The blue gate indicates the per-
centage of cells in early S-phase and the green gate indicates the late S-phase. The red gate at the 9 h time point indicates 
the early S-phase + G1-phase of the next cycle. (A) U2OS cells transfected with scrambled siRNA were pulsed with BrdU 
for 30 min and the DNA replication was followed after its withdrawal for 0–6–9 h in cells. The cells were stained with an 
anti-BrdU specific antibody and counterstained with propidium iodide (PI). (B) As in panel A but with U2OS cells silenced 
for Pol λ with the specific siRNA si98. (C) BJ-hTERT cells transfected with scrambled siRNA were pulsed with BrdU for 1 
h and the DNA replication was followed after its withdrawal for 12 h in cells. The cells were stained with an anti-BrdU 
specific antibody and counterstained with propidium iodide (PI). (D) As in panel C but with BJ-hTERT cells silenced for 
Pol λ with the specific siRNA si98. (E) Quantification of cells in late S (green bars) or next G1 (red bars) for BJ-hTERT cells 
transfected with scrambled siRNA (Control) or silenced for Pol λ with the specific siRNA si98 (Pol λ KD). Values are the 
mean of three independent measurements. Error bars represent S.D. n.s., not statistically significant (Student’s t-test). 
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Together, these results suggested a direct relationship between Pol λ levels and ALT 
activity, as measured by c-circles and APBs formation. Since telomeres are replicated in 
the late-S phase, the observed cell cycle delay upon Pol λ silencing is consistent with a 
possible role of Pol λ in aiding telomeric ends replication and/or processing. 
2.3. DNA Polymerase λ Can Catalyze Annealing and Elongation of a G-Rich Telomeric Strand 
to a Complementary C-Rich Telomeric Template Sequence 
ALT-dependent telomere elongation requires that a G-rich ss telomere DNA over-
hang is annealed to the complementary strand present on either chromosomal telomere 
DNA or c-circles. This mechanism involves enzymes able to catalyze DNA strand transfer 
and annealing reactions, followed by DNA synthesis. We have recently shown that Pol λ 
possesses robust microhomology-mediated strand annealing and elongation activities on 
normal or repetitive DNA sequences. We termed this activity microhomology mediated 
strand transfer (MMST) [26]. 
The ability of Pol λ to perform MMST synthesis of telomeric DNA was then tested 
with two model substrates, which may be relevant for ALT. First, a 16/48 primer-template 
(Figure 4A top left scheme) was used, with a dideoxy-terminated primer end, so that no 
elongation could take place. A ss 25 mer oligonucleotide, containing a 3′-terminal telo-
meric sequence (TTAGGGTTA) complementary to positions +4 – +12 of the 16/48 template 
strand (denoted in black in Figure 4A, top), was then supplemented in trans at the begin-
ning of the reaction, which was carried out at 37 °C. Since theoretical Tm for spontaneous 
annealing of the telomeric 3′-terminal sequence to its complementary template strand is 
19.2 °C, at the non-permissive temperature used for the assay, very little annealing should 
occur, unless stabilized by Pol λ. Addition of Pol λ and all four dNTPs resulted in efficient 
full-length synthesis (Figure 4A, lanes 1–5). Products of the length expected from the tem-
plate sequence downstream to the microhomology region appeared only in the presence 
of the correct nucleotide combinations (Figure S1A, lanes 3–8), but not with the 25mer 
donor alone (Figure S1A, lanes 10–14). No nucleotide incorporation was observed in the 
presence of the dideoxy-terminated 16/48 mer template alone, whose 16 mer primer was 
5′-labelled (Figure S1B), indicating that DNA synthesis by Pol λ was dependent upon pre-
cise annealing of the primer, supplemented in trans, to a microhomology region on the 
template strand. Moreover, the closely related X-family Pol β could not efficiently replace 
Pol λ in this reaction, suggesting that this activity was specific for Pol λ (Figure S1C). 




Figure 4. Microhomology-mediated strand transfer and DNA synthesis by DNA polymerase λ on telomere sequences is 
regulated by RP-A and POT1/TPP1. DNA templates are shown on top of each panel. Black boxes indicate the annealing 
site on the 5′-labelled primer and template strands. (A) Titration of Pol λ alone (lanes 1–5; 11–15) or in combination with 
25 nM RP-A (lanes 6–10; 16–20), in the presence of the 16/48 linear (lanes 1–10) or the 48/48 “bubble” (lanes 11–20) acceptor 
DNA templates. (B) Titration of dideoxy-terminated 16/48mer (lanes 2–11) or 48/48mer “bubble” (lanes 12–21) acceptor 
DNA templates, in the presence of dGTP and in the absence (lanes 2–6; 12–16) or in the presence (lanes 7–11; 17–21) of 25 
nM RP-A. (C) Dose-response curves of nucleotide incorporation (pmols) by Pol λ in the absence (clear symbols) or pres-
ence (filled symbols) of 25 nM RP-A on the linear (circles) or bubble (triangles) substrates illustrated in panel B. Values are 
the mean of two measurements ± S.E. (D) Titration of Pol λ on the 48/48mer “bubble” template, in the absence (lanes 1–4) 
or in the presence (lanes 5–12) of different amounts of the POT1/TPP1 complex. (E) Titration of Pol λ on the 48/48mer 
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“bubble” template (25 nM), in the absence (lanes 11–13) or in the presence (lanes 1–10) of different amounts of the 
POT1/TPP1 complex. Lane 1: control in the absence of enzyme. (F) Quantification of nucleotide incorporation by increasing 
amounts of Pol λ in the absence (filled circles) or in the presence of increasing amounts of POT1/PP1 as indicated in panel 
E. Values are the mean of two measurements ±S.E. (G) Pol λ activity on the 48/48 mer acceptor template in the absence 
(lane 2) or in the presence (lanes 3–6) of increasing amounts of POT1/TPP1. (H) Titration of the 48/48 mer acceptor template 
in the presence of Pol λ and in the presence (lanes 1–5) or in the absence (lanes 6–9) of POT1/TPP1. (I) Dose-response 
curves of nucleotide incorporation (pmols) by Pol λ in the absence (clear symbols) or presence (filled symbols) of 15 nM 
POT1/TTP1 on the bubble substrate shown in panel H. Values are the mean of two measurements ± S.E. 
Next, the 48 mer acceptor DNA template was annealed to a complementary 48 mer 
oligonucleotide, bearing a stretch of 16 non-complementary nucleotides in the central re-
gion, forming a D-loop structure, with an ss “bubble”, encompassing the telomeric -
AATCCCAAT- sequence required for the 25 mer ss donor DNA to anneal (Figure 4A, top 
right scheme). A 25mer ss donor DNA, bearing a complementary telomeric sequence, 
within the “bubble”, was provided in trans to mimic the G-rich strand invasion proposed 
to occur in vivo during ALT. Again, Pol λ was able to promote annealing and elongation 
of the donor 25 mer, reaching the end of the template (Figure 4A, lanes 11–15), indicating 
strand displacement activity. 
2.4. Replication Protein A Restricts DNA Polymerase λ Microhomology-Mediated Strand 
Transfer Activity 
RP-A and POT1/TPP1 are important regulators of telomeres homeostasis and ALT 
[3,30–33]. We therefore tested whether these proteins affected also the MMST reaction by 
Pol λ. 
First, Pol λ was titrated with the 16/48 and 48/48 substrates, in the presence of the 
heterotrimeric human RP-A at 1:1 M/M ratio with the DNA substrate. RP-A inhibited the 
overall DNA synthesis on both substrates (Figure 4A lanes 6–10; 16–20). Titration of both 
the linear and “bubble” acceptor templates in the presence of RP-A (Figure 4B), showed 
that RP-A reduced the efficiency of substrate utilization (Vm/Km) by Pol λ on both sub-
strates (Figure 4C and Table 1), suggesting that the effect of RP-A was not dependent on 
the nature of the DNA template. The inhibitory effect of RP-A could be reduced by in-
creasing the number of target sequences on the template strand. In fact, the efficiency of 
the MMST DNA synthesis reaction in the presence of RP-A was higher on a 5xtel-16/48 
mer acceptor DNA bearing four possible annealing sites (Figure S1D, lanes 1–5), than on 
the 16/48 mer with a single site (Figure S1D, lanes 6–10). Overall, the affinity of Pol λ for 
the 5xtel-16/48 target DNA was increased 2-fold (Table 1). 
Table 1. Effect of RP-A on the kinetic parameters for template binding by DNA polymerase λ dur-
ing MMST DNA synthesis. 
Acceptor Template 16/48 16/48 5xtel 48/48 Bubble 
 −RP-A +RP-A +RP-A −RP-A +RP-A 
Km (nM) 12 ± 1 21 ± 2 11 ± 1 43 ± 4 124 ± 10 
Vmax (nM × min−1) 9 ± 1 7 ± 1 7.5 ± 0.7 9 ± 1 10 ± 1 
Vmax/Km (min−1) 0.75 0.33 0.68 0.21 0.08 
-fold reduction Vmax/Km  2.27 1.1  2.62 
Thus, RP-A acts as a negative regulator of MMST by Pol λ, likely preventing the an-
nealing between the donor and the template DNA substrates. 
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2.5. The POT1/TPP1 Complex Stimulates the Microhomology-Mediated Strand Transfer 
Activity of DNA Polymerase λ 
Next, the POT1/TPP1 complex was tested in the MMST reaction with Pol λ. As shown 
in Figure 4D, in the presence of a 5′-labelled 26-mer ss donor DNA strand, bearing the 
consensus sequence for POT1 binding (5′-TTAGGGTTAG-3′), in combination with a “bub-
ble” 48-mer template (Figure 4D, top scheme), contrary to RP-A, the addition of 
POT1/TPP1 stimulated MMST primer elongation by low concentrations of Pol λ (Figure 4D, 
compare lanes 1, 2 with lanes 5, 6, 9, 10). The best stimulation was observed between 15 
nM or 30 nM POT1/TPP1 and Pol λ between 30 and 60 nM (Figure 4E, F; Figure S8). Excess 
of Pol λ (Figure 4D, compare lanes 3, 4 with lanes 7, 8, 11, 12) or of POT1/TPP1 (Figure 
4E,F) resulted in less or no stimulation. POT1/TPP1 increased the MMST activity of Pol λ 
also under conditions were DNA synthesis was limited to the first 6–7 nt (Figure 4G, com-
pare lane 2 with lanes 3–6; Figure S6), that is before full strand displacement (Figure 4G, 
top scheme). This suggested that POT1/TPP1 increased the ability of the Pol λ-primer 
complex to find its target template, rather than its strand displacement activity. To directly 
test this hypothesis, the 48/48mer bubble template was titrated in the reaction under the 
same limiting conditions. As shown in Figure 4H and Figure S7), POT1/TPP1 increased 
the DNA substrate utilization efficiency by Pol λ (Figure 4I). 
Thus, contrary to RP-A, the POT1/TPP1 complex positively influenced the MMST 
activity of Pol λ. 
2.6. TERRA RNA Can Function as a Substrate for the Microhomology-Mediated Strand Trans-
fer Activity by DNA Polymerase λ 
The long noncoding RNA TERRA has been shown to form RNA/DNA hybrid struc-
tures (R-loops) at telomeres, especially in ALT cells, where TERRA levels are usually 
higher than in telomerase-positive cells. These R-loops have been proposed to function 
also as starting points for ALT DNA synthesis [34]. R-loops are also strong DNA replica-
tion blocks, whose bypass may involve replication fork restart [12]. Since we have previ-
ously shown that Pol λ has the unique ability to elongate an RNA primer annealed to a 
DNA template [35], we tested whether Pol λ was able to promote MMST DNA synthesis 
on our 16/48 mer template, starting from an RNA primer containing a telomeric repeat 
sequence at its 3′-end (26mer TERRA). As shown in Figure 5A, Pol λ was indeed able to 
promote annealing and elongation of the 26mer TERRA primer, but to a much lower ex-
tent than its equivalent DNA primer (Figure 5A, compare lanes 2–6, with lanes 9–14). A 
similar drop in efficiency was observed also on the 48/48mer bubble template (Figure 5B, 
compare lanes 2–3 with lanes 10–11), where most of the TERRA-primed synthesis stopped 
immediately before the ss/ds junction (product +4, Figure 5B top scheme), while full length 
products were synthesized when the 26 mer DNA primer was used. 




Figure 5. TERRA RNA represses the strand transfer activity by DNA polymerase λ and is counteracted by POT1/TPP1. 
(A) Time course of MMST synthesis by Pol λ with the 26 mer donor DNA (lanes 1–6) or the 26 mer TERRA donor RNA 
(lanes 8–14) and the 5xtel 16/48 mer acceptor template. Lane 7, reaction with the 26 mer donor DNA without the acceptor 
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template. Lane 15, reaction with the 26 mer TERRA donor RNA without the acceptor template. (B) Titration of 26mer 
TERRA (lanes 2–8) or the 26mer DNA (lanes 9–16) in the DNA-dependent (lanes 2–8) or TERRA-dependent (lanes 9–16) 
MMST reaction catalyzed by Pol λ on the 48/48mer bubble acceptor template. (C) Dose response curves of the inhibition 
of Pol λ synthesis by the competitor 26mer TERRA (circles) or 26mer DNA (triangles) shown in panel B. Values are the 
mean of two measurements ± S.E. (D) Titration of 26mer TERRA in the DNA-dependent MMST reaction catalyzed by Pol 
λ on the 48/48mer bubble acceptor template, in the absence (lanes 2–6) or presence (lanes 7–21) of increasing POT1/TPP1 
concentrations. (E) Dose response curves of the inhibition of Pol λ synthesis by the competitor 26mer TERRA, in the ab-
sence (triangles) or in the presence of increasing amounts of POT1/TPP1. Values are the mean of two measurements ± S.E. 
2.7. The POT1/TPP1 Complex Favors the Microhomology-Mediated Strand Transfer Activity by 
DNA Polymerase λ Starting from Telomeric DNA Over TERRA RNA 
Since TERRA RNA can be used as a primer by Pol λ, we next asked whether and to 
what extent its presence could interfere with the DNA-primed MMST DNA synthesis. To 
this aim, competition experiments were carried out on the 48/48mer bubble template, ei-
ther in the presence of fixed-labeled 26mer DNA and increasing amounts of unlabeled 
26mer TERRA (Figure 5B, lanes 4–8), or with a fixed labeled 26mer TERRA primer and 
increasing amounts of unlabeled 26mer DNA (Figure 5B, lanes 12–16). Both unlabeled 
competitors (either RNA or DNA) were able to reduce MMST synthesis by Pol λ (Figure 5B, 
compare lanes 2, 3 and 10, 11 with lanes 4–8 and 12–16, respectively) with similar affinities 
(Figure 5C). The POT1/TPP1 complex was able to increase the rate of the DNA-primed 
MMST reaction by Pol λ. Consistently, the presence of POT1/TPP1 reduced the ability of 
TERRA to inhibit the DNA-primer MMST reaction (Figure 5D, compare lanes 2–6, with 
lanes 7–21) in a dose-dependent manner (Figure 5E). 
Colocalization of Pol λ and TERRA was also attempted in Saos-2 cells. Supplemen-
tary Figure S2 A shows an example of colocalization of Pol λ foci (as visualized by α-cMyc 
Abs) and TERRA foci (as visualized by TERRA-specific FISH). The TERRA foci were sen-
sitive to RNase A treatment, confirming their RNA nature (Figure S2B). However, colo-
calization events were very rare and analysis on a representative number of fields failed 
to show statistical significance (Figure S2A). This might reflect a very transient nature of 
the interaction between Pol λ and TERRA, making it difficult to capture a sufficient num-
ber of events in living cells. 
In summary, POT1/TPP1 favors DNA-primed MMST DNA synthesis by Pol λ, effec-
tively counteracting its inhibition by TERRA. 
2.8. DNA Polymerase λ Associates with Telomeres and TPP1 in ALT Cells 
The interaction of Pol λ with telomeric DNA was investigated by immunofluores-
cence analysis and confocal microscopy on Saos-2 cells, stably expressing ectopic Myc-
tagged Pol λ and on U2OS cells. Saos-2 cells were synchronized in S-phase by a low dose 
of HU and then released for 6 h before analysis, in order to enrich the population of late 
S-phase cells. Figure 6A shows an example of colocalization of telomeric DNA, detected 
by telomere-specific FISH, and Pol λ foci, detected by α-Myc Abs. A total of 62 cells were 
analyzed, corresponding to 1254 Pol λ foci and 4830 telomeric-positive foci, respectively 
(Figure 6B). Since we observed only between 1 to 3 colocalization events per cell (Figure 6C), 
we performed a statistical analysis comparing the number of colocalization events ob-
served vs. those predicted to occur under the hypothesis of a random distribution of foci, 
which indicated that the colocalization was statistically significant (Figure 3D). 




Figure 6. DNA polymerase λ associates with telomeres in ALT cells. (A) Confocal microscopy imaging of Pol λ colocali-
zation with telomeres in Saos-2 λ13 cell clone stably expressing c-Myc Pol λ. A representative colocalization event is indi-
cated by the white arrow. (B) The number of signals (foci) detected, respectively, for Pol λ (circles) and telomeres (trian-
gles) within a single cell is shown. (C) Number of observed colocalization events per cell. (D) Statistical analysis comparing 
the expected number (n) of colocalization events under the hypothesis of random chance colocalization, with the number 
of observed colocalizations. χ2 p value is shown on top of the bars. ***, χ2 p value < 0.005. 
In order to confirm that Pol λ and TPP1 colocalize in ALT cells, colocalization be-
tween Pol λ (visualized by α-cMyc Abs) and TPP1 (visualized by α-TPP1 Abs) was per-
formed on Saos-2 cells expressing Myc-Pol λ, synchronized with HU and released for 6 h 
(Figure 7A). A total of 1243 TPP1 foci (range 5–203/cell) and 349 Pol λ foci (range 11–
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40/cell) were detected (Figure 7B). Since we observed only between 1 to 5 colocalization 
events per cell (Figure 7C), we performed a statistical analysis comparing the number of 
colocalization events observed vs. those predicted to occur under the hypothesis of a ran-
dom distribution of foci, which indicated that the colocalization was statistically signifi-
cant (Figure 7D). These results indicated that only a fraction of Myc-Pol λ colocalized with 
TPP1. This can be explained by the fact that Pol λ acts also on non-telomeric chromosomal 
DNA and the interaction of Pol λ and TPP1 likely occurs only in the subset of TPP1 foci, 
which are engaged in ALT. 
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Figure 7. DNA polymerase λ associates with TPP1 in ALT cells (A-D Saos-2; E-H U2OS). (A) Confocal microscopy imaging 
of Pol λ colocalization with TPP1 in Saos-2 cells stably expressing c-Myc Pol λ. The white arrow indicates a representative 
colocalization event. (B) Number of foci detected for Myc-Pol λ (circles) and TPP1 (tringles) per cell. (C) Number of ob-
served colocalization events per cell. (D) Statistical analysis comparing the expected number (n) of Pol λ-TPP1 colocaliza-
tion events under the hypothesis of random chance colocalization, with the number of observed colocalizations. χ2 p values 
are shown on top of the bars. (E) Confocal microscopy imaging of Pol λ colocalization with TPP1 in U2OS cells. The white 
arrow indicates representative colocalization events in a single stack. (F) Number of observed foci for Pol λ (circles) and 
TPP1 (triangles) per cell. G. Number of observed colocalization events per cell. (H) Statistical analysis comparing the 
expected number (n) of Pol λ-TPP1 colocalization events under the hypothesis of random chance colocalization, with the 
number of observed colocalizations. χ2 p values are shown on top of the bars. ***, χ2 p value < 0.005. 
Moreover, the same analysis was performed on endogenous Pol λ in unsynchronized 
U2OS cells. Figure 7E shows an example of endogenous Pol λ and TPP1 colocalizations. 
A total of 3461 TPP1 foci (range 29–42/cell) and 2550 Pol λ foci (range 1–103/cell) were 
detected (Figure 7F). In this case, we observed a higher number of colocalization events 
per cell (Figure 7G). Once again, statistical analysis under random distribution hypothesis 
revealed effective colocalization of the two factors (Figure 7H). 
All together, these experiments indicated that Pol λ can associate with telomeric 
DNA in ALT cells. 
2.9. DNA Polymerase λ Silencing Induces Telomere Stress Specifically in ALT Cells 
Telomere dysfunctions can induce DNA damage at telomeres, which results in the 
appearance of foci of DNA damage response proteins such as P53BP1 at telomeres. Thus, 
we investigated whether silencing of Pol λ in ALT cells was sufficient to induce such te-
lomere dysfunction-induced foci (TIFs). To this aim, colocalization of TPP1 with P53BP1 
was analyzed by confocal microscopy in Saos-2 and U2OS cells either wt or treated with 
Pol λ-specific siRNA. Figure 8A,C show examples of colocalizations between P53BP1 and 
TPP1 respectively in Saos-2 and U2OS cells silenced for Pol λ (Pol λ KD). In both ALT cell 
lines, as shown in Figure 8B,D, Pol λ deficiency results in a statistically significant higher 
number of TIFs containing both P53BP1 and TPP1, with respect to wt cells. When a similar 
analysis was performed on BJ-hTERT cells, which use telomerase-dependent elongation 
of the telomeric DNA ends, no statistically significant difference between wild type and 
Pol λ KD cells was observed (Figure 8E). 
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Figure 8. DNA polymerase λ silencing causes telomere stress specifically in ALT cells. (A) Confocal microscopy imaging 
of TPP1 colocalization with P53BP1 (telomere dysfunction foci, TIF) in Saos-2 cells silenced for Pol λ. The white arrows 
indicate representative colocalization events (TIF). (B) Quantification of TPP1-P53BP1 colocalization events through 
JACoP plug-in of ImageJ. 103 and 106 cells were analyzed, respectively, for cells treated with scramble control siRNA 
(Control) and for cells silenced for Pol λ (siPolL). Each circle and triangle represents the amount of colocalizing signal 
within a single cell. These data are quantified by M2 Mander’s overlap coefficients, that are 0.7702 (SD = 0.06734) for cells 
treated with scrambled control siRNA and 0.8537 (SD = 0.06885) for cells silenced for Pol λ. Error bars represent ±SD. p-
values were calculated through two-tailed Student’s t-test (95% confidence interval) (C) Confocal microscopy imaging of 
TPP1 colocalization with P53BP1 (telomere dysfunction foci, TIF) in U2OS cells silenced for Pol λ. The white arrows indi-
cate representative colocalization events (TIF). (D) Statistical analysis comparing the number of TPP1-P53BP1 colocaliza-
tion events in U2OS treated with scrambled control siRNA (control) or treated with anti-Pol λ siRNA (siPolL). n. of ana-
lyzed cells = 100 for each condition. χ2 p value is shown on top of the bars. (E) Statistical analysis comparing the number 
of TPP1-P53BP1 colocalization events in BJ-hTERT cells treated with scrambled control siRNA (control) or treated with 
anti-Pol λ siRNA (siPolL). n. of analyzed cells = 53 for each condition. χ2 p value is shown on top of the bars. n.s., not 
significant, χ2 p > 0.02. 
3. Discussion 
ALT is exploited for telomere maintenance in a wide range of human cancers [36] 
and is particularly frequent in osteosarcoma and glioblastomas [37,38]. All the proposed 
mechanisms for ALT initiation involve annealing and elongation by a Pol of a G-rich te-
lomere strand to a complementary C-rich template, often in the context of D-loop struc-
ture [1,39]. However, which and how many Pols are involved in ALT synthesis is still 
imperfectly known. 
Here, we have shown that Pol λ has an intrinsic ability to promote MMST synthesis 
within a D-loop template, bearing C-rich telomere repeats, mimicking the G-rich strand 
invasion known to occur during ALT. In vivo, Pol λ colocalizes with TPP1 and the 
POT1/TPP1 complex stimulates Pol λ activity in vitro. Conversely, RP-A and TERRA neg-
atively regulate this reaction. The strand displacement activity of Pol λ observed even in 
our minimal in vitro system, might be relevant in promoting rolling circle replication 
through the ds regions of a c-circle template. RP-A has been shown to prevent G-rich ss 3′ 
overhang elongation in ALT cells [40]. One hypothesized mechanism was that RP-A pre-
vented annealing of the 3′ ss overhang to the ECTRs, thus impeding rolling circle ampli-
fication. Our in vitro data showing repression by RP-A of the initial annealing step of 
MMST synthesis mediated by Pol λ on both linear and D-loop templates, fully support 
this hypothesis. The c-circles are believed to represent intermediates of rolling circle-type 
amplification of telomeres, likely formed at the levels of APBs and their levels decline 
rapidly when ALT is inhibited [7]. Consistently, we have shown that Pol λ silencing re-
duces c-circle levels and APBs formation, while its overexpression increases c-circles for-
mation. In vivo, replacement of POT1/TPP1 with RP-A at G-rich overhangs of telomeres 
is favored by TERRA and promotes the HR-dependent ALT mechanism [3,31,34]. Con-
versely, rolling circle replication starting from c-circles is HR-independent [7]. Thus, our 
results showing a direct correlation between Pol λ levels and the accumulation of c-circles 
might suggest a role for Pol λ in this HR-independent ALT mechanism. 
Telomeres in ALT cells are particularly prone to replication stress and DSBs for-
mation [10,11]. Repair of DSBs at internal telomeric sequences has been shown to involve 
a microhomology-mediated a-NHEJ mechanism, which starts with 5′-end resection of the 
broken ends, to create ss overhangs [17]. The resulting ss G-strand is bound by the 
POT1/TPP1 complex, which prevents further resection. The a-NHEJ represses ALT by re-
pairing the break before it can be used for strand invasion. However, the ss G-strand 
bound by the POT1/TPP1 complex formed during the process could also be used to initi-
ate ALT by invasion of another telomere or by annealing to ECTR molecules such as c-
circles. We observed that Pol λ depletion increases P53BP1 foci at telomeres in ALT cells, 
suggesting Pol λ participation in DSBs repair at telomeres. Given that Pol λ has been 
shown to participate in microhomology-mediated NHEJ [26], its ability to interact with 
POT1/TPP1 might also promote ALT initiation as a consequence of aberrant a-NHEJ of 
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internal DSBs at telomeres. Interestingly, Pol λ has been shown to be upregulated in many 
cancer types, including thyroid, ovary and lung carcinomas [41]. These malignancies have 
been often found to lack telomerase, thus Pol λ overexpression might increase aberrant 
repair events, leading to ALT initiation. 
The ability of Pol λ to promote annealing and elongation of a DNA strand within a 
D-loop structure, could also suggest additional roles of this enzyme in telomere replica-
tion. Telomeres are regions difficult to replicate, due to their repetitive sequences and po-
tential secondary structures, which can lead to replication fork stalling and replication 
stress. Indeed, D-loop-type structures are very frequent at telomeres in ALT cells, due to 
the high levels of TERRA [13,34]. Annealing of TERRA at telomeric DNA generates R-
loops that are strong blocks for a DNA replication fork and need to be bypassed [12]. 
Based on our findings, it is possible to hypothesize that, upon fork stalling at the R-loop, 
Pol λ could use the 3′-OH end of the TERRA RNA to prime DNA synthesis, resulting in a 
short tract of DNA, which could be used for repriming by the replication fork. Upon deg-
radation of TERRA, known to occur during S-phase, a gap will be left behind the advanc-
ing replisome, to be filled by postreplicational DNA repair (possibly by Pol λ itself). Al-
ternatively, a model could be envisaged, where, upon fork collapsing, the 3′-end of the 
leading strand will re-anneal at a microhomology region downstream the TERRA RNA. 
Pol λ and the POT1/TPP1 complex could favor this process, allowing Pol λ itself initiating 
a synthesis at the leading strand. Indeed, three lines of evidence stemming from our work 
support a role for Pol λ in counteracting replication stress: (i) the increased sensitivity to 
HU-induced fork stalling observed in ALT cells, when combined with silencing of Pol λ 
(this work and [28]); (ii) the delay in progression through late-S/G2 phase in Pol λ silenced 
ALT cells; and (iii) the induction of DNA damage foci at telomeres upon Pol λ silencing 
in ALT cells. 
Depletion of the specialized TLS enzyme Pol η in ALT cells has been shown to induce 
elevated levels of ALT activity and sister chromatic exchanges between telomeric ends 
[24]. It has been proposed that Pol η works in an HR-dependent mechanism for restarting 
the stalled replication fork, or allows bypass of replication blocks such as G-quadruplexes 
or oxidative lesions, thereby preventing DSB formation and BIR-dependent ALT. On the 
other hand, Pol η did not seem to play a role in DSBs repair at telomeres. Our data showed 
that depletion of Pol λ has the opposite effect, namely to repress ALT, while its overex-
pression increases ALT activity. Thus, it seems that Pol η and Pol λ involvement in repli-
cation stress tolerance at telomeres in ALT cells has different outcomes. While Pol η pro-
motes a general bypass of replication blocks avoiding DSB formation, Pol λ could be in-
volved in more specific events, such as R-loops bypass or a-NHEJ DSBs repair, which 
could also prime ALT synthesis, especially in the presence of elevated levels of Pol λ. 
4. Conclusions 
In summary, the data presented in this work unveil a previously unnoticed link be-
tween Pol λ levels and ALT activity in tumor cells. ALT-positive tumors have been asso-
ciated with higher invasively and poorer prognosis [42–44]. Thus, our data suggest a pos-
sible exploitation of Pol λ as a potential anticancer target for ALT-positive tumors. 
5. Materials and Methods 
5.1. Chemicals 
[γ-32P]ATP (6000 Ci/mmol) was from GE Healthcare Biosciences; unlabeled dNTPs 
were from Roche Molecular Biochemicals. All other reagents were of analytical grade and 
were purchased from Merck or Fluka. 
Nucleic acids substrates. The sequences are: 
Acceptor linear (16ddC/48mer) 
5′-CAGTCGATCGATCGAc (c = ddC) 
3′-GTCAGCTAGCTAGCTGCCAATCCCAATCCCAACTATAGAGCGCTGTCA-5′ 
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5′-CAGTCGATCGATCGAc (c = ddC) 
3′-GTCAGCTAGCTAGCTGCCAATCCCAATCCCAATCCCAATCCCAATCCC-5′ 
5xtel acceptor bubble (5xtel48mer_comp_bub/5xtel48mer) 
5′-CAGTCGATCGATCGACAAAACAAAAACAAAAAAGGGTTAGGGTTAGGG-3′ 
3′-GTCAGCTAGCTAGCTGCCAATCCCAATCCCAATCCCAATCCCAATCCC-5′ 
25 mer donor 
5′-GTCAGCTAGCTAGCTATTAGGGTTA-3′ 
26 mer donor 
5′-GTCAGCTAGCTAGCTATTAGGGTTAG-3′ 
26 mer TERRA 
5′-GUCAGCUAGCUAGCUAUUAGGGUUAG-3′ 
All substrate oligonucleotides and their corresponding primers were purified on a 
15%(w/v) polyacrylamide, 7 M urea, 30% formamide gel. After elution and ethanol pre-
cipitation, their concentrations were determined spectrophotometrically. Bold letters in-
dicate the non-complementary regions introduced to obtain the “bubble” structure. Un-
derlined sequences indicate the microhomology regions available for annealing. Telo-
meric repeats are shaded in grey. The 25-, 29- 32- and 35-mer oligonucleotides were 5′ 
labelled with T4 polynucleotide kinase (New England Biolabs) in the presence of [γ-
32P]ATP. The 26-mer donor oligonucleotide was synthesized with a fluorescent group (6-
FAM) at its 5′-end. Each labelled primer was mixed to the complementary template oligo-
nucleotide at 1:1 (M/M) ratio in the presence of 25 mM Tris-HCl (pH 8.0) and 50 mM KCl, 
heated at 80 °C for 3 min and then slowly cooled down at room temperature. 
5.2. Proteins production and purification. 
Recombinant His-tagged human wild-type Pol λ, and human RP-A, were expressed 
and purified as described [45]. Human Pol β was from TREVIGEN. After purification, the 
proteins were >90% homogenous, as judged by SDS–PAGE and Coomassie staining. The 
cDNA of POT1 and TPP1 genes were cloned into pEAK8 vector for mammalian expres-
sion of flag-tagged POT1 and non-tagged TPP1 driven by the EF1-a promoter. Protein 
expression was carried out by transient transfection of both POT1 and TPP1 expression 
plasmids on a 1:1 ratio into HEK293E cells for 72 h as described [46]. The cells were then 
harvested and lysed in NETN buffer (40 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM 
EDTA, 0.5% NP40) supplemented with a protease inhibitor cocktail (Roche) and centri-
fuged at 15,000g for 20 min. After centrifugation, anti-flag M2 affinity gel (Sigma) was 
added to the supernatant and incubated at °C for 4 h, followed by washes with NETN 
buffer and PBS. The POT1/TPP1 complex was eluted into PBS plus 10% glycerol by TEV 
protease cleavage at 4 °C for 5 h, and TEV protease was subsequently removed by Ni-
NTA agarose (Qiagen). The activity of the purified POT1/TPP1 complex was determined 
by its ability of binding to the telomeric G-stranded oligo (TTAGGG)3 and to stimulate 
telomerase activity in vitro [46]. 
5.3. Cell lines and treatments. 
Saos-2 and U2OS (osteosarcoma) cell line and BJ-hTERT (hTERT-immortalized fibro-
blasts) were grown in Dulbecco modifies Eagle medium (DMEM) complemented with 
10% fetal bovine serum at 37 °C and 5% CO2. Pol λ over-expressing Saos-2 clones were 
grown in DMEM complemented with 10% fetal bovine serum and 500 µg/mL of G418 
(Sigma Aldrich) at 37 °C and 5% CO2. Hydroxyurea was purchased by Sigma Aldrich. 
Approximately 5 × 103 U2OS and Saos-2 cells and 2.5 × 103 BJ-TERT cells were seeded in 
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96-well plate and treated for 24 h at 37 °C with hydroxyurea at the indicated concentra-
tions, then the cell viability was recorded following 24 h of recovery. To synchronize cells 
for immunofluorescence, clones were treated with 1mM HU for 24 h and fixed in 4% PFA 
after 6 h of recovery, during the S-phase. Approximately 106 U2OS and Saos-2 cells were 
seeded in two 10 cm2 plates for the c-circle assay in order to perform DNA extraction. 
5.4. Protein extracts. 
To prepare whole-cell extracts, cells were re-suspended into one packed cell volume 
of buffer containing 10 mM Tris-HCl (pH 7.8), 200 mM KCl, 1× protease inhibitor cocktail 
(Sigma Aldrich) and 1 mM PMSF. Two packed cell volumes of buffer containing 10 mM 
Tris-HCl (pH 7.8), 600 mM KCl, 40% glycerol, 0.1 mM EDTA and 0.2% Nonidet P-40 was 
then added and mixed thoroughly before rocking the cell suspension for 2 h at 4 °C. The 
cell lysate was then centrifuged at 15,000 rpm at 4 °C for 20 min and the supernatant was 
collected, aliquoted and stored at −80 °C. 
5.5. Cytotoxicity assay. 
The CellTiter 96 Aqueous One Solution cell proliferation assay (Promega) was used 
as a colorimetric method for determining the toxicity induced during treatments. Briefly, 
the day before treatment cells were seeded into 96 well-plates (density 1000–10,000 
cells/well). To evaluate the treatment effects, the medium was replaced with 100 µL of 
fresh complete medium and 20 µL of cell titer reagent; then, after incubation at 37 °C for 
at least 3 h, the absorbance at 492 nm was recorded. 
5.6. RNA interference. 
Cells were transfected using Lipofectamine RNAiMAX reagent (Life Technologies) 
according to the manufacturer’s protocol. To target Pol λ transcript it was used either the 
siRNA Selective Validated signal 26198 (si98) 5′-CAAAAGUACUUGCAAAGAUTT-3′ 
and Silencer Select Negative Control siRNA #1 (scrambled control) from Ambion, or the 
siRNA-SMARTpool (M-008746-00-0005, siGENOME human POLL (27343) from Darma-
con, comprising four different validated siRNAs with the sequences: 5′-GGGCAGAACU-
CUUUGAGAA-3′; 5′-GGAGGAGGCUACAGAGAUU-3′; 5′-GGAAGCGGAUGGCUGA-
GAA-3′; 5′-GACCAAGACUGCCCAGAUG-3′. si98 and SMARTpool gave similar Pol λ 
silencing efficiencies. 
5.7. Pol λ over expression stable cell lines.  
Saos-2 and U2OS cells were grown on 10 cm dishes to 80% confluence and then the 
cells were transfected with Lipofectamine RNAiMAX transfection reagent (Life Technol-
ogies) following the manufacturer`s protocol in the presence of 2 µg of purified plasmid, 
pcDNA3-polλ-Myc or the empty vector. Following 24 h after transfection, cells were split 
to the optimal plating density of a 3 × 105 cells/dish and incubated further for 24 h before 
the start of the selection process. The optimized selective concentration of G418 was 1 
mg/mL. The obtained clones were grown in medium containing 500 µg/mL G418 and the 
Pol λ expression was checked by Western blot and immunofluorescence assay to select 
the most proficient clones. The clone Saos λ13 displayed the highest Pol λ expression, 
while Saos EV was the empty vector control. 
5.8. Immunofluorescence. 
5.8.1. Pol λ and TPP1 colocalization.  
Saos-2. 105 cells/mL were seeded on glass coverslips 24 h prior to the synchronization 
with 1 mM HU for 24 h, followed by the 6 h recovery before the subsequent 10mM HU 
treatment for 24 h. Primary antibodies were anti-PTOP mouse monoclonal antibody 
(ab57595, Abcam) and anti-Myc tag rabbit polyclonal antibody (ab9106, Abcam); second-
ary antibodies were anti-rabbit Alexa Fluor 555 and anti-mouse Alexa Fluor 488 (Life 
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Technologies). Nuclei were stained by ProLong Gold solution (Life Technologies). The 
medium was removed and the coverslips were gently washed once in PBS for 5′ in agita-
tion. Extraction was performed with CSK buffer (10 mM Hepes Buffer pH 7.4, 100 mM 
NaCl, 300 mM sucrose, 3 mM MgCl2) + 0.5% Triton for 2′, followed by a 5 min-wash in 
CSK buffer in agitation. Cells were fixed in 4% PFA in PBS for 10′ (Paraformaldehyde 16% 
solution Electron Microscopy Science) on ice. Cell permeabilization was achieved through 
PBS Triton 0.1% for 3 min. After 3 washes in PBS, the coverslips were stored in 3% BSA in 
PBST 0.1% at 4 °C until staining. The coverslips were incubated with primary antibody 
for 2h at RT in humid chamber: α-Myc tag (rabbit) 1:250 in 3% BSA with PBS Tween 0.1% 
and α-PTOP (mouse) 1:50 in 3% BSA with PBS Tween 0.1%. After washing in PBS, the 
coverslips were incubated for 1 h RT in humid chamber with the secondary antibodies α-
rabbit (donkey) 1:5000 and α-mouse (goat) 1:1000 in 3% BSA with PBS Tween 0.1%, 
washed in PBS in dark and mounted on slides with Prolong Gold antifade reagent with 
DAPI (Invitrogen). 
U2OS. 3 × 105 cells were seeded on glass coverslips for 24 h. Primary antibodies were 
anti-ACD (TPP1) rabbit polyclonal antibody (ab220740, Abcam) and anti-Pol λ mouse 
monoclonal antibody (sc-373844, Santa-Cruz); secondary antibodies were anti-rabbit 
Alexa Fluor 488 (ab150077, Abcam) and anti-mouse Alexa Fluor 555 (ab150114, Abcam). 
Nuclei were stained with DAPI (1:250,000 in PBS). Extraction was performed with CSK 
buffer (10 mM Hepes Buffer pH 7.4, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl2) + 0.5% 
Triton for 2′, followed by a 5 min-wash in CSK buffer in agitation. Cells were fixed in 4% 
PFA in PBS for 10′ (Paraformaldehyde 16% solution Electron Microscopy Science) on ice. 
Cell permeabilization was achieved through PBS Triton 0.1% for 3 min. After 3 washes in 
PBS, the coverslips were stored in 3% BSA in PBST 0.1% at 4 °C until staining. The co-
verslips were incubated with primary antibody for 2 h at RT in a humid chamber: α-TPP1 
(rabbit) 1:100 in 3% BSA with PBS Tween 0.1% and α-Pol λ (mouse) 1:500 in 3% BSA with 
PBS Tween 0.1%. After washing in PBS, the coverslips were incubated for 1 h RT in a 
humid chamber with the secondary antibodies α-rabbit (goat) 1:2000 and α-mouse (don-
key) 1:1500 in 3% BSA with PBS Tween 0.1%. Following two washes for 5′ in 3% BSA in 
1X PBS and one wash in 1X PBS for 5′, coverslips are incubated with DAPI (1:250,000) at 
RT for 10′. Finally, coverslips are washed twice in 1X PBS and mounted with mounting 
solution (Aqua-Poly/Mount, Polysciences) and stored at 4 °C in dark. Pol λ and TPP1 foci, 
colocalizations and nuclei were counted and quantified using ComDet (Fiji) plugin [47]. 
The best-fit lower threshold was determined using the threshold tool and visually in-
spected. Images were acquired using a 63X objective on confocal microscope (Zeiss). Cell 
nuclei were visualized at 405nm (DAPI) and foci at 555nm (TRITC) or 488nm (FITC). 
5.8.2. TPP1 and P53BP1 colocalization.  
For Saos-2 cells: 75X104 SAOS-2 cells were seeded in 10 mm dishes and transfected 
with 100 pmol of siRNA C- or 100 pmol of siRNA POLL through the use of lipofectamine 
RNAiMAX (Invitrogen) for 120 h. Cells were harvested at 85–90% of confluence and uti-
lized to validate silencing through Western Blot analysis. At 120 h of silencing coverslips 
were moved to 24-well plates and washed once in filtered 1× PBS for 5′ at 4 °C. Extraction 
of soluble proteins is performed using CSK buffer + 0.5% Triton for 2′. After a washing for 
5′ in CSK buffer, cells are fixed in 4% PFA. Cells are subsequently permeabilized using 1× 
PBS + Triton 0.1% for 3′ on ice and washed 3 times for 5′ in 1× PBS. Blocking is carried out 
in 3% BSA in 1× PBS Tween 0.1% at 4 °C O/N. After 3 washes in 1X PBS1 for 5′ in ice, 
coverslips were incubated with primary antibodies for 1 h at RT in humid chamber. α-
53BP1 (goat, Bethyl, A303-906A) 1:2000 and α-ACD (TPP1 Abcam, ab220740, rabbit) 1:100 
in 3% BSA in 1X PBS Tween 0.1% were utilized. After 3 washes for 5′ in 3% BSA in 1× PBS 
on ice, coverslips were incubated with secondary antibodies for 1 h at RT in humid cham-
ber. α-goat Alexa 555 (Invitrogen, A21432) (1:800) and α-rabbit Alexa 488 (Abcam, 
ab150077) (1:2000) in 3% BSA in 1× PBS Tween 0.1%. were utilized. Following two washes 
for 5′ in 3% BSA in 1X PBS and one wash in 1× PBS for 5′, coverslips are incubated with 
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DAPI (1:250,000) at RT for 10′. Finally, coverslips are washed twice in 1× PBS and mounted 
with mounting solution (Aqua-Poly/Mount, Polysciences) and stored at 4 °C in the dark. 
TPP1-P53BP1 colocalization events were quantified using JACoP (Just Another Colocali-
zation Plug-in) ImageJ colocalization tool [48]. M2 Manders’ overlap coefficient estimates 
the amount of colocalizing signal from one channel (green,TPP1) over the other 
(red,P53BP1) [49,50]. The best-fit lower threshold was determined using the threshold tool 
and was viusully inpected. 
For U2OS cells: 105 cells/mL were seeded on glass coverslips 24 h prior to the syn-
chronization with 1 mM HU for 24h, followed by the 6 h recovery. Proteins were detected 
with anti-PTOP mouse monoclonal antibody (ab57595, Abcam) at 1:50 dilution and with 
α-53BP1 (goat, Bethyl, A303-906A) at 1:2000 dilution. The secondary Abs used were α-
goat (donkey) Alexa Fluor 488 at 1:400 + α-mouse 555 (donkey) at 1:300 dilution, respec-
tively. Protein colocalizations were analysed using the software ImageJ and CellProfiler 
[48]. 
Images were acquired using a 60× objective on confocal microscope (Zeiss). Cell nu-
clei were visualized at 405 nm (DAPI) and foci at 555 nm (TRITC) or 488 nm (FITC). 
5.8.3. Immunofluorescence-FISH and APBs detection.  
Saos-2 λ13 cells were seeded on glass coverslips 24 h prior to the synchronisation 
with 1mM HU for 24 h, followed by 6 h recovery. U2OS cells were transfected by siRNA 
C- or siRNA POLL; 24 h after transfection, cells were seeded on coverslip and fixed 24 h 
later. 
Cells on coverslips were fixed in 4% PFA for 15 min at room temperature, washed 2 
times in PBS, permeabilized in a 0.2% triton solution for 10 min at RT and saturated in 
PBS, BSA 3% solution for 30 min. 
PML immunostaining: PML detection was performed by the mouse monoclonal α-
PML antibody (SantaCruz SC966) diluted 1/250 in PBS, 1% BSA, 0.1% triton for 2 h at RT 
followed by 3 washes in PBS and incubation with an alexa-488 goat anti mouse secondary 
antibody for 1 h at RT. After incubation with the secondary antibody, cells were washed 
in PBS, incubated in 2% PFA for 5 min at RT and washed again. 
For telomeres FISH detection, cells were treated with 100 µg/mL RNase A in SCC2X, 
for 1 h at 37 °C in dark. After 2 washes in SSC 2×, samples are treated with increasing 
ethanol concentration: 70% EtOH, 85% EtOH, 100% EtOH. For the hybridization step, cells 
are incubated with PNA (Peptide Nucleic Acid) Telomere C-rich Cy3-labelled probe 
67µg/mL (MIX QPCRPanagene) diluted 1:80 in hybridization buffer at 80 °C for 10′, for 
DNA denaturation, and at 30 °C O/N for probe hybridization with telomeric DNA se-
quences. Coverslips are washed in SSC 0.4× + 0.3% NP-40 at 68 °C for 3′ and SSC 2X + 0.1% 
NP-40 at RT for 1′. Nuclear DNA is stained with DAPI solution 1:5000 in PBS for 5′ in dark. 
Coverslips are mounted on slides with fluorescent mounting medium (Dako) and stored 
at 4 °C. 
Cells were visualized at the confocal microscope (Zeiss) with 488 nm laser for FITC 
(Myc tag), 561 nm laser for Cy3 (for telomeric probe) and 405 nm for DAPI. 
5.9. Terra RNA FISH.  
Cells were seeded on coverslips 12 h before immunostainings. To prevent RNA deg-
radation ribonucleoside-vanadyl complex—an inhibitor of various ribonucleases—was 
added to all the solutions and buffers used to a final concentration of 10 mM, except for 
the negative control slides treated with RNaseA. Cells were fixed and permeabilized with 
3.6% formaldehyde; 0.3% Triton X-100; 1× PBS for 10 min and washed 3 times with 1X PBS 
for 5 min/wash. For the negative control, slides were treated with 0.1 mg/mL RNAseA for 
1 h at 37 °C in a humid chamber and washed 3 times with 1X PBS for 5 min/wash. Cells 
were dehydrated with 70% ethanol, 95% ethanol and kept overnight at −20 °C in 100% 
ethanol. Next day, the cells were air-dried and incubated with pre-denatured telomeric C-
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rich PNA probes coupled with FITC (Panagene # F1001). The probe was diluted in hybrid-
ization buffer to the final concentration of 50 mM and denatured at 85 °C for 10 min (it is 
important to denature only the probes not in contact with the cells to avoid unspecific 
binding with denatured DNA). Cells were incubated with the probe for 30 min at 37 °C in 
a humid chamber and washed 3 times with 2× SSC containing 50% formamide for 20 min 
at 42 °C, and quickly washes 3 times with 2× SSC at RT. Next, immunostaining was per-
formed as described above. 
5.10. Cell cycle analysis.  
The U2OS and BJ-hTERT cells were pulsed with 30 µM BrdU (Sigma,Aldrich,) for 30 
min or 1 h and the DNA replication was followed after its withdrawal, respectively, for 
0–6–9 or 12 h in cells transfected with scrambled siRNA or after silencing of POLL. The 
cells were then fixed in 1 mL of cold 70% ethanol and stored at 4 °C overnight. DNA was 
denatured with 2N HCl/0.5% Triton X-100 and neutralized with 1 mL of 0.1M sodium 
borate pH8.5. After centrifugation at 500g for 10 min, the cell pellet was resuspended with 
a mouse anti-BrdU antibody (1:100; Becton Dickinson,), diluted in 1% BSA, PBS 0.5% 
Tween 20, and incubated for 1 h at room temperature. Cells were then centrifuged at 500 
g for 10 min and the pellet was resuspended with anti-mouse-488 (1:500; Alexa anti mouse 
488, Molecular Probes/Invitrogen) and incubated for 1 h at room temperature. Samples 
were finally incubated with 10 ug/mL Propidium Iodide and analysed on a S3 flow cy-
tometer (Bio-rad). Data were analysed using the program ProSort (Bio-rad) or FCS Ex-
press (DeNovo).  
5.11. CC-Assay.  
4 µg of genomic DNA were digested at 37 °C O/N with HinfI and RsaI (Thermo sci-
entific) and RNase A (Sigma-Aldrich) in Buffer Tango 1x (Thermo scientific). 100 µL of 
digested DNA solution were subjected to isothermal amplification by incubation at 30 °C 
for 8h with 100 µL of Amplification Mix (0.2 mg/mL BSA, 0.1% Tween, 1 mM dNTPs) in 
the presence of ϕ29 Pol in its Reaction Buffer (Thermo scientific). Then DNA samples were 
spotted on a nylon transfer membrane (GeneScreen Hybridization Transfer Membrane, 
PerkinElmer), pre-hydrated in distilled H2O for 10′, using Bio-Dot Microfiltration Appa-
ratus (Biorad). The membrane was then crosslinked on both sides with 254 nm UV radia-
tion at 1200 J in order to covalently bind DNA to the membrane, washed 2 times in SSC2× 
for 5′ in agitation. Subsequently, the membrane was blocked in pre-hybridization buffer, 
pre-heated at 65 °C for 2 h (PerfectHyb Plus Hybridization Buffer, Sigma-Aldrich). The 
membrane was incubated with the C-rich 60-mer probe 5′-CCC TAA CCC TAA CCC TAA 
CCC TAA CCC TAA CCC TAA CCC TAA CCC TAA CCC TAA CCC TAA-3′ (bio-
mers.net), 5′ labelled with T4 polynucleotide kinase (New England Biolabs) in the pres-
ence of [γ-32P]ATP, at 65 °C O/N. After washes, the membrane was dried and exposed to 
a phosphor screen for 24 h. The signal was detected by phosphorimaging (Typhoon, GE 
Healthcare). 
5.12. Enzymatic assays.  
For denaturing gel analysis of DNA synthesis products, the reaction mixtures con-
tained 50 mM Tris-HCl (pH 7.0), 0.25 mg/mL BSA, 1 mM DTT, the dNTP’s as indicated in 
the figures and the indicated amounts of the 5′ 32P-labelled donor and the corresponding 
acceptor templates. Donor and acceptor templates were added at the beginning of the re-
action along with the other reagents, without previous pre-incubation and/or annealing. 
A final Mg++ concentration of 1 mM was used. Concentrations of Pols, RP-A, POT1/TPP1 
and dNTPs were as indicated in the respective Figures. Reactions were incubated 10 min 
at 37 °C, unless otherwise stated, and then stopped by addition of standard denaturing 
gel loading buffer (95% formamide, 10 mM EDTA, xylene cyanol and bromophenol blue), 
heated at 95 °C for 3 min and loaded on a 7 M urea/10% polyacrylamide gel. 
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5.13. Steady state kinetic analysis.  
Reactions were performed as described above. Quantification was done by scanning 
densitometry. The initial velocities of the reaction were calculated from the values of in-
tegrated gel band intensities: I*T/IT-1, where T is the target site, the template position of 
interest; I*T is the sum of the integrated intensities at positions T, T + 1,…, T + n. All the 
intensity values were normalized to the total intensity of the corresponding lane to correct 
for differences in gel loading. 
The apparent Km and kcat values were calculated by plotting the initial velocities in 
dependence of the 3′-OH concentrations (DNA) and fitting the data according to the Mich-
aelis–Menten Equation: 
v = kcat[E]0/(1 + Km/[DNA]) (1)
where [E]0, was the input enzyme concentration and kcat/[E]0 = Vmax. Substrate utilization 
efficiencies were defined as the Vmax/Km ratio. Kinetic constants were derived fitting the 
experimental data to the appropriate equations with the computer program GraphPad 
Prism 3.0. 
Dose-response curves for the inhibition of Pol l synthesis were fitted to the Equation: 
v = V0/(1 + [I]/IC50) (2)
where V0 is the apparent velocity of the reaction without the inhibitor, [I] is the variable 
inhibitor concentration and IC50 is the inhibitory potency, defined as the concentration of 
the inhibitor reducing the enzyme activity by 50%. Kinetic constants were derived fitting 
the experimental data to the appropriate equations with the computer program GraphPad 
Prism 3.0. 
5.14. Statistical analysis.  
As indicated in the Figure legends, mean values for each series of samples corre-
sponding to the different conditions were analyzed by the computer program GraphPad 
Prism 3.0. Student’s t test was applied to paired samples. For Pol λ colocalization with 
telomeres and TPP1, statistical tests were applied combining all experiments from each 
series due to the limitations in numbers. The number of expected colocalizations was cal-
culated as the product of the total dot positions in the cell area (i.e., calculated in pixel) 
and the combined frequency of dots obtained with different antibodies. The total number 
of possible dot positions in the cell was calculated as the number of dots contained in the 
cell area with a sliding area corresponding to a half of the dot size that represents the limit 
of visual resolution. Differences between the number of expected and observed colocali-
zation were evaluated by the Chi-square goodness-of-fit test. 
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Abbreviations 
ALT Alternative Lengthening of Telomeres 
Pol DNA Polymerase 
POT1/TTP1 Protection of Telomeres protein 1 
HR Homologous Recombination 
RP-A Replication Protein A 
ECRTs Extra-Chromosomal Telomeric Repeats 
DSBs Double Strand Breaks 
aNHEJ Alternative Microhomology-Mediated Non-Homologous End Joining Pathway 
PARP-1 Poly (ADP-Ribose) Polymerase 
BIR Break Induced Replication 
TLS Translesion Synthesis 
MMST Microhomology Mediated Strand Transfer 
HU Hydroxyurea 
PML ALT-associated promyelocytic leukemia 
TERRA Telomeric Repeats Containing RNA 
TIFs telomere dysfunction-induced foci 
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